ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13

April 10, 1981

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012

In Brief: Murphy To Head Pediatric Oncology Group; DeVita To Receive ACCC Research Award

May 1, 1992

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

November 22, 2013

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976